Ara
Toplam kayıt 6, listelenen: 1-6
May regional anesthesia be a better choice for the COVID-19 pandemic?
(Springer, 2020)
To the Editor; The novel coronavirus disease 2019 (COVID-19) is a global pandemic and threat all over the world. The first cases were seen in, Wuhan, China, in December 2019 (Chen et al. 2020a). This novel coronavirus was ...
Combined metabolic activators accelerates recovery in mild-to-moderate COVID-19
(Wiley, 2021)
COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD(+)) and glutathione metabolism. Here it is investigated if administration ...
Olfactory cleft measurements and COVID-19-related anosmia
(Sage Publications Ltd, 2021)
Objective. This study aimed to investigate the differences in olfactory cleft (OC) morphology in coronavirus disease 2019 (COVID-19) anosmia compared to control subjects and postviral anosmia related to infection other ...
From asymptomatic to critical illness: Decoding various clinical stages of COVID-19
(The Scientific and Technological Research Council of Turkey, 2021)
The clinical course of COVID-19 is variable, with clinical manifestation ranging from 81% mild course to 14% severe course along with 5% critical course in patients. The asymptomatic course is reported to potentially range ...
Covid-19: Pathogenesis, genetic polymorphism, clinical features and laboratory findings
(TUBITAK Scientific & Technological Research Council of Turkey, 2020)
COVID-19 caused by a novel agent SARS-CoV-2 progressed to a pandemic condition and resulted in a major public health concern worldwide, leading to social and economic issues at the same time. The pathogenesis of COVID-19 ...
A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma
(Tübitak Scientific & Technical Research Council Turkey, 2020)
Background/aim: A SARS-Cov2 infection which was first arised from Wuhan in December 2019 and named as COVID-19. Still there lacks either a specific treatment or a vaccine to treat COVID-19. Convalescent plasma (CP) was ...